ArticlePloS one2014

The relevance of testing the efficacy of anti-angiogenesis treatments on cells derived from primary tumors: a new method for the personalized treatment of renal cell carcinoma.

Renaud Grépin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.